Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 285 participants.
Also called NCT01983449
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 285 participants
- Sponsor
- Mercator MedSystems, Inc.
- Registry
-
NCT01983449
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01983449. Allocation not applicable; no masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2016-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
- Acronym
- DANCE
- Condition
- Peripheral Arterial Diseases
- Intervention (Drug)
- Dexamethasone Sodium Phosphate Injection, USP
- Lead sponsor
- Mercator MedSystems, Inc.
Record details
- Record id
cardio:ct-nct01983449- Content hash
3326b6fedd5566021c6874a73fec93931be4ae183ee4d74bc017de6596df0d83